Tamibarotene是RARα激动剂,能诱导HL-60细胞体外分化和凋亡,ED50为0.79 nM。
Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Sanda T, et al. Leukemia, 2005, 19(6), 901-909.
[2] The effect of Am-80, a synthetic retinoid, on spinal cord injury-induced motor dysfunction in rats By Takenaga, Mitsuko; Ohta, Yuki; Tokura, Yukie; Hamaguchi, Akemi; Shudo, Koichi; Okano, Hideyuki; Igarashi, Rie From Biological & Pharmaceutical Bulletin (2009), 32(2), 225-231.
[3] A retinoic acid receptor agonist Am80 rescues neurons, attenuates inflammatory reactions, and improves behavioral recovery after intracerebral hemorrhage in mice By Matsushita, Hideaki; Hijioka, Masanori; Hisatsune, Akinori; Isohama, Yoichiro; Shudo, Koichi; Katsuki, Hiroshi From Journal of Cerebral Blood Flow & Metabolism (2011), 31(1), 222-234.
分子式 C22H25NO3 |
分子量 351.44 |
CAS号 94497-51-5 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 70 mg/mL |
Water <1 mg/mL |
Ethanol 70 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00520208 | Acute Promyelocytic Leukemia | Drug: Tamibarotene | CytRx | Phase 2 | 2007-09-01 | 2013-02-11 |
NCT01337154 | Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion|Stage IV Non-small Cell Lung Cancer | Drug: Tamibarotene|Drug: Placebo | CytRx | Phase 2 | 2011-04-01 | 2013-06-27 |
NCT00985530 | Acute Promyelocytic Leukemia | Drug: Tamibarotene|Drug: Arsenic trioxide | Northwestern University|CytRx|Cephalon | Phase 1 | 2009-10-01 | 2013-10-28 |
NCT01343355 | HTLV-I-Associated Myelopathy | Drug: Tamibarotene | St. Marianna University School of Medicine | Phase 2|Phase 3 | 2011-01-01 | 2011-07-21 |
NCT01226147 | Lupus Nephritis | Drug: Tamibarotene | Kinki University | Phase 2 | 2010-09-01 | 2011-07-21 |
NCT01120002 | Alzheimer's Disease | Drug: Tamibarotene|Drug: Placebo | Osaka City University | Phase 2 | 2010-05-01 | 2011-07-21 |
NCT00417391 | Crohn's Disease | Drug: RR110 (Tamibarotene)|Drug: RR110 (Tamibarotene) | R&R Inc. | Phase 2 | 2006-12-01 | 2008-05-25 |
NCT02807558 | Acute Myeloid Leukemia|Myelodysplastic Syndrome | Drug: SY-1425 (tamibarotene)|Drug: azacitidine | Syros Pharmaceuticals | Phase 2 | 2016-08-01 | 2017-03-22 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们